AIM ImmunoTech Inc
AIM ImmunoTech Inc., an immuno-pharma company, focuses on the research and development of therapeutics to treat multiple types of cancers, viral diseases, and immune-deficiency disorders in the United States. The company's lead product candidate is Ampligen, a drug of macromolecular ribonucleic acid molecules for the treatment of chronic fatigue syndrome (CFS). It is also developing Ampligen for … Read more
AIM ImmunoTech Inc (AIM) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of March 2025: 0.612x
Based on the latest financial reports, AIM ImmunoTech Inc (AIM) has a cash flow conversion efficiency ratio of 0.612x as of March 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-2.36 Million) by net assets ($-3.86 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
AIM ImmunoTech Inc - Cash Flow Conversion Efficiency Trend (1995–2024)
This chart illustrates how AIM ImmunoTech Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
AIM ImmunoTech Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of AIM ImmunoTech Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Natural Capsules Limited
NSE:NATCAPSUQ
|
0.022x |
|
Jeju Beer Co. Ltd.
KQ:276730
|
-0.248x |
|
2BO
F:2BO
|
-2.415x |
|
Kanoria Chemicals & Industries Limited
NSE:KANORICHEM
|
0.015x |
|
Zhong Yang Financial Group Limited Ordinary Shares
NASDAQ:TOP
|
0.209x |
|
CATERPILLAR - Dusseldorf Stock Exchang
DU:CAT1
|
0.184x |
|
Malam Team
TA:MLTM
|
0.085x |
|
Aureka Ltd
AU:AKA
|
-0.359x |
Annual Cash Flow Conversion Efficiency for AIM ImmunoTech Inc (1995–2024)
The table below shows the annual cash flow conversion efficiency of AIM ImmunoTech Inc from 1995 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $-1.32 Million | $-14.89 Million | 11.262x | +641.93% |
| 2023-12-31 | $10.23 Million | $-21.27 Million | -2.078x | -396.27% |
| 2022-12-31 | $38.47 Million | $-16.11 Million | -0.419x | -70.55% |
| 2021-12-31 | $56.88 Million | $-13.96 Million | -0.246x | -45.15% |
| 2020-12-31 | $61.29 Million | $-10.37 Million | -0.169x | +75.92% |
| 2019-12-31 | $12.91 Million | $-9.07 Million | -0.702x | +65.84% |
| 2018-12-31 | $5.17 Million | $-10.64 Million | -2.056x | -125.38% |
| 2017-12-31 | $8.70 Million | $-7.94 Million | -0.912x | -91.61% |
| 2016-12-31 | $15.50 Million | $-7.38 Million | -0.476x | +39.57% |
| 2015-12-31 | $20.37 Million | $-16.05 Million | -0.788x | -41.57% |
| 2014-12-31 | $25.00 Million | $-13.92 Million | -0.557x | +3.10% |
| 2013-12-31 | $29.30 Million | $-16.83 Million | -0.574x | -95.47% |
| 2012-12-31 | $44.70 Million | $-13.14 Million | -0.294x | -10.51% |
| 2011-12-31 | $37.97 Million | $-10.10 Million | -0.266x | -2.80% |
| 2010-12-31 | $45.95 Million | $-11.89 Million | -0.259x | -73.57% |
| 2009-12-31 | $62.38 Million | $-9.30 Million | -0.149x | +81.61% |
| 2008-12-31 | $11.54 Million | $-9.36 Million | -0.811x | -12.41% |
| 2007-12-31 | $20.95 Million | $-15.11 Million | -0.721x | -29.84% |
| 2006-12-31 | $24.75 Million | $-13.75 Million | -0.555x | -52.26% |
| 2005-12-31 | $19.84 Million | $-7.24 Million | -0.365x | -1.17% |
| 2004-12-31 | $20.08 Million | $-7.24 Million | -0.361x | +52.52% |
| 2003-12-31 | $9.25 Million | $-7.02 Million | -0.759x | +45.79% |
| 2002-12-31 | $4.58 Million | $-6.41 Million | -1.401x | -107.04% |
| 2001-12-31 | $10.76 Million | $-7.28 Million | -0.676x | +3.04% |
| 2000-12-31 | $11.57 Million | $-8.07 Million | -0.698x | -26.59% |
| 1999-12-31 | $12.70 Million | $-7.00 Million | -0.551x | -42.00% |
| 1998-12-31 | $15.20 Million | $-5.90 Million | -0.388x | +9.71% |
| 1997-12-31 | $10.70 Million | $-4.60 Million | -0.430x | +58.42% |
| 1996-12-31 | $5.90 Million | $-6.10 Million | -1.034x | -139.43% |
| 1995-12-31 | $4.40 Million | $-1.90 Million | -0.432x | -- |